Current Status of Understanding the Pathogenesis and Management of Patients With NOMID/CINCA

Translational Autoinflammatory Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health, Building 10, Room 6D-47B, 10 Center Drive, Bethesda, MD 20892, USA.
Current Rheumatology Reports (Impact Factor: 2.45). 04/2011; 13(2):123-31. DOI: 10.1007/s11926-011-0165-y
Source: PubMed

ABSTRACT Neonatal-onset multisystem inflammatory disease (NOMID)/chronic infantile neurologic, cutaneous, and arthritis (CINCA) syndrome is the most severe clinical phenotype in the spectrum of cryopyrin- (NLRP3/NALP3) associated periodic syndromes (CAPS). The study of patients with NOMID/CINCA has been instrumental in characterizing the extent of organ-specific inflammatory manifestations and damage that can occur with chronic interleukin (IL)-1β overproduction. Mutations in CIAS1/NLRP3 lead to constitutive activation of the "NLRP3 inflammasome," an intracellular platform that processes and secretes increased amounts of IL-1β. The pivotal role of IL-1β in NOMID/CINCA has been demonstrated in several clinical studies using IL-1--blocking agents that lead to rapid resolution of the inflammatory disease manifestations. NOMID/CINCA is a monogenic autoinflammatory syndrome; and the discovery of the role of IL-1 in NOMID has led to the exploration in the role of IL-1 in other disorders including gout and Type II diabetes. The inflammation in NOMID/CINCA is continuous with intermittent flares, and organ manifestations encompus the central nervous system, eye, inner ear, and bones. This review discusses updates on the pathogenesis of NOMID/CAPS, emerging long term-outcome data regarding IL-1--blocking agents that have influenced our considerations for optimal treatment, and a monitoring approach tailored to the patient's disease severity and organ manifestations.

Download full-text


Available from: Raphaela Goldbach-Mansky, Jul 08, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Das Cryopyrin-assoziierte periodische Syndrom (CAPS) ist eine äußerst seltene Erkrankung. Schätzungen gehen von 1 bis 2 Fällen auf 1 Mio. Menschen in den USA und 1/360.000 in Frankreich aus. Da viele Patienten nicht oder nur sehr spät diagnostiziert werden, dürfte die tatsächliche Prävalenz höher liegen. CAPS umfasst die 3 Entitäten FCAS („familial cold autoinflammatory syndrome“), das Muckle-Wells-Syndrom (MWS) und das NOMID („neonatal-onset multisystem inflammatory disease“)/CINCA („chronic infantile neurologic, cutaneous and articular“)-Syndrom. Gemeinsam ist diesen Erkrankungen eine ursächliche Mutation im NRLP3-Gen. Das veränderte Genprodukt Cryopyrin führt zur Aktivierung des Inflammasoms mit exzessiver Ausschüttung von IL-1β. IL-1β ist für die inflammatorischen Manifestationen von CAPS verantwortlich. Diese äußern sich als systemische und lokale Entzündung mit Fieber, Kopfschmerz, Fatigue, Hautausschlag, Augenbeteiligung, progressiver Hörminderung, muskuloskelettalen Beschwerden und ZNS-Manifestation (nur NOMID/CINCA). Mit den IL-1-Inhibitoren Anakinra, Rilonacept und Canakinumab stehen erstmals effektive und sichere Therapieoptionen für diese stark beeinträchtigende Erkrankung zur Verfügung. Um schwere und zum Teil lebensbedrohliche Krankheitsfolgen zu verhindern, sind eine frühe korrekte Diagnose und ein möglichst frühzeitiger Therapiebeginn unerlässlich.
    Zeitschrift für Rheumatologie 04/2012; 71(3). DOI:10.1007/s00393-011-0856-9 · 0.46 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In clustering, usually a single point or vector is used as a cluster prototype. The idea of clustering about principal curves has been recently introduced. Principal curves are functions that can characterize a set of nonlinear data. One way to create a principal curve is to apply a one-dimensional self-organizing map to the multidimensional data. In this paper, the mixture of self-organizing maps algorithm is presented. Results with respect to a color image segmentation task are shown and discussed
    Neural Networks, 2002. IJCNN '02. Proceedings of the 2002 International Joint Conference on; 02/2002
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Innate immune receptors such as the nucleotide-binding domain, leucine-rich repeat-containing (NBD-LRR) receptors, referred to as NLRs, are known to serve as a critical component of host defense. However, their participation in inflammatory responses within immune privileged sites such as the brain and eye is less understood. The potential importance of NLRs in regulation of inflammation within these particular sites is further underscored by their association with autoinflammatory disorders, wherein localized inflammation can occur within the brain or eye as neuroinflammation or uveitis, respectively. Many NLRs are expressed within the brain and eye and in this review, we discuss their roles in the inflammation of the central nervous system (CNS) and uveitis.
    Current Opinion in Pharmacology 08/2011; 11(4):423-8. DOI:10.1016/j.coph.2011.07.002 · 4.23 Impact Factor

Similar Publications